ArticleAntibiotics (Basel, Switzerland)2022

Neurodegenerative Disease Treatment Drug PBT2 Breaks Intrinsic Polymyxin Resistance in Gram-Positive Bacteria.

David M P De Oliveira et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.